A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Table 4 Estimated budget impact during fiscal years 2008 to 2022 of provision of HSCT to 200 severe thalassemic patients (aged 1-10) per year

Estimated budget impact (million THB)			Incremental budget
Fiscal year	BT-ICT	Related HSCT
2008	7	98	91
2009	14	104	90
2010	20	103	83
2011	26	102	76
2012	32	101	69
2013	37	100	63
2014	42	99	57
2015	46	99	53
2016	50	98	48
2017	54	97	43
2018	58	96	38
2019	61	95	34
2020	64	93	29
2021	67	92	25
2022	69	91	22
Total	647	1,468	821

BT-ICT: blood transfusion combined with subcutaneous iron chelating therapy; HSCT: hematopoietic stem cell transplantation; and THB: Thai baht (in 2008 value).

ISSN: 1472-6963